GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
Sirona Biochem Corp.
WKN: A0RM6R / Name: Sirona / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /
0,038 €
8,70 %
GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
VANCOUVER, British Columbia, June 18, 2024 -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has
Unlock the benefits of Tirzepatide, a premium peptide designed to support weight loss and improve energy levels. This high-quality product is trusted for its effectiveness and reliability. Enhance your wellness journey with Tirzepatide, and experience the superior quality and results it offers. Start your path to a healthier lifestyle today.
Der Beitrag wurde gelöscht
Neueste Beiträge
juliamaribell in 5 Countries Where Casino Stock Investments Make Strong Sense, travel BV ADR